Effectiveness of medical device class 3 HAIRCARE in treatments androgenetic alopecia
Phase 3
- Conditions
- Androgenic alopecia.Androgenic alopecia
- Registration Number
- IRCT20230401057792N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Men and women with hereditary hormonal hair loss
Exclusion Criteria
Severe allergic reaction to the injection
Receiving any topical or systemic medication in the last 3 months for hair loss
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The thickness of the hair. Timepoint: The third and sixth sessions and one month after the end of the treatment. Method of measurement: by the hair analyzer.;Hair density. Timepoint: The third and sixth sessions and one month after the end of the treatment. Method of measurement: by the hair analyzer.
- Secondary Outcome Measures
Name Time Method Patient satisfaction score of treatment. Timepoint: After the third and sixth sessions and one month after the treatment. Method of measurement: Based on patient global assessment score.;Doctor's satisfaction. Timepoint: After the third and sixth sessions and one month after the treatment. Method of measurement: Based on Physician global assessment score.;Tolerability of treatment. Timepoint: during treatment. Method of measurement: questionnaire.